Pharsight

Drugs that contain Glucagon

1. Baqsimi patents expiration

BAQSIMI's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6938798 AMPHASTAR PHARMS INC Fluid or powdery product dispensing device
Jan, 2022

(2 years ago)

US10213487 AMPHASTAR PHARMS INC Nasal powder formulation for treatment of hypoglycemia
Feb, 2036

(11 years from now)

US10894133 AMPHASTAR PHARMS INC Device for dispensing a fluid product
Jan, 2038

(13 years from now)

US10765602 AMPHASTAR PHARMS INC Medication delivery systems and methods
Sep, 2039

(15 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jul 24, 2022

Market Authorisation Date: 24 July, 2019

Treatment: Treatment of severe hypoglycemia in patients with diabetes

Dosage: POWDER;NASAL

More Information on Dosage

BAQSIMI family patents

Family Patents

2. Gvoke Hypopen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649364 XERIS Methods for producing stable therapeutic formulations in aprotic polar solvents
Apr, 2036

(11 years from now)

US11590205 XERIS Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
Apr, 2036

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 10, 2022

Market Authorisation Date: 10 September, 2019

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

GVOKE HYPOPEN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Gvoke Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11590205 XERIS Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
Apr, 2036

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 10, 2022

Market Authorisation Date: 10 September, 2019

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

GVOKE KIT family patents

Family Patents

4. Gvoke Pfs patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649364 XERIS Methods for producing stable therapeutic formulations in aprotic polar solvents
Apr, 2036

(11 years from now)

US11590205 XERIS Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
Apr, 2036

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 10, 2022

Market Authorisation Date: 10 September, 2019

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

GVOKE PFS family patents

Family Patents